Total Payments
$70,911
2024 Payments
$2,655
Companies
12
Transactions
49
Medicare Patients
279
Medicare Billing
$59,189
Payment Breakdown by Category
Consulting$35,791 (50.5%)
Research$28,021 (39.5%)
Other$5,280 (7.4%)
Travel$1,197 (1.7%)
Food & Beverage$619.23 (0.9%)
Education$2.09 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $35,791 | 20 | 50.5% |
| Unspecified | $28,021 | 7 | 39.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,280 | 1 | 7.4% |
| Travel and Lodging | $1,197 | 6 | 1.7% |
| Food and Beverage | $619.23 | 14 | 0.9% |
| Education | $2.09 | 1 | 0.0% |
Payments by Type
General
$42,890
42 transactions
Research
$28,021
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Arbor Pharmaceuticals, Inc. | $28,021 | 7 | $0 (2020) |
| Ipsen Biopharmaceuticals, Inc | $7,593 | 8 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $7,185 | 6 | $0 (2018) |
| JAZZ PHARMACEUTICALS INC. | $5,913 | 3 | $0 (2019) |
| Genentech USA, Inc. | $5,872 | 4 | $0 (2017) |
| SERVIER PHARMACEUTICALS LLC | $4,080 | 1 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $3,709 | 3 | $0 (2023) |
| Amgen Inc. | $3,614 | 7 | $0 (2020) |
| AbbVie, Inc. | $1,962 | 3 | $0 (2018) |
| Stemline Therapeutics Inc. | $1,920 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,655 | 3 | Ipsen Biopharmaceuticals, Inc ($2,610) |
| 2023 | $5,973 | 4 | SERVIER PHARMACEUTICALS LLC ($4,080) |
| 2022 | $2,321 | 2 | Stemline Therapeutics Inc. ($1,920) |
| 2021 | $3,879 | 3 | Ipsen Biopharmaceuticals, Inc ($3,879) |
| 2020 | $5,836 | 2 | Arbor Pharmaceuticals, Inc. ($5,768) |
| 2019 | $10,247 | 12 | Arbor Pharmaceuticals, Inc. ($3,591) |
| 2018 | $14,510 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($7,185) |
| 2017 | $25,491 | 12 | ARBOR PHARMACEUTICALS, INC. ($18,662) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) | Food and Beverage | In-kind items and services | $44.80 | General |
| Category: TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | ||||||
| 08/23/2024 | Ipsen Biopharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $1,305.00 | General |
| 06/28/2024 | Ipsen Biopharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $1,305.00 | General |
| 11/24/2023 | Ipsen Biopharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $652.50 | General |
| 11/16/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $41.86 | General |
| Category: Clinical Trial Product_PI | ||||||
| 09/27/2023 | SERVIER PHARMACEUTICALS LLC | — | Consulting Fee | Cash or cash equivalent | $4,080.00 | General |
| 09/14/2023 | Bayer Healthcare Pharmaceuticals Inc. | Vitrakvi (Drug) | Consulting Fee | Cash or cash equivalent | $1,198.75 | General |
| Category: Oncology | ||||||
| 09/28/2022 | Stemline Therapeutics Inc. | — | Consulting Fee | Cash or cash equivalent | $1,920.00 | General |
| 01/01/2022 | Ipsen Biopharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $401.25 | General |
| 07/09/2021 | Ipsen Biopharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 04/15/2021 | Ipsen Biopharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $401.25 | General |
| 02/05/2021 | Ipsen Biopharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $1,337.50 | General |
| 03/12/2020 | Arbor Pharmaceuticals, Inc. | Gliadel (Drug) | — | Cash or cash equivalent | $5,768.33 | Research |
| Study: Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry (VIGILANT) • Category: Neurology | ||||||
| 01/27/2020 | Amgen Inc. | — | Food and Beverage | Cash or cash equivalent | $67.21 | General |
| 12/10/2019 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| 11/19/2019 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $59.84 | General |
| 11/19/2019 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $11.83 | General |
| 11/18/2019 | Amgen Inc. | — | Travel and Lodging | In-kind items and services | $168.62 | General |
| 11/18/2019 | Amgen Inc. | — | Travel and Lodging | In-kind items and services | $143.60 | General |
| 11/04/2019 | Ipsen Biopharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $50.00 | General |
| 09/13/2019 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $412.50 | General |
| 09/10/2019 | Arbor Pharmaceuticals, Inc. | Gliadel (Drug) | — | Cash or cash equivalent | $1,064.00 | Research |
| Study: Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry VIGILANT • Category: Neurology | ||||||
| 07/15/2019 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Consulting Fee | Cash or cash equivalent | $2,450.00 | General |
| Category: Oncology | ||||||
| 05/30/2019 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: Oncology | ||||||
| 03/04/2019 | Arbor Pharmaceuticals, Inc. | Gliadel (Drug) | — | Cash or cash equivalent | $2,527.00 | Research |
| Study: Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry VIGILANT • Category: Neurology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry VIGILANT | ARBOR PHARMACEUTICALS, INC. | $18,662 | 4 |
| Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry (VIGILANT) | Arbor Pharmaceuticals, Inc. | $5,768 | 1 |
| Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry VIGILANT | Arbor Pharmaceuticals, Inc. | $3,591 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 124 | 277 | $159,927 | $24,683 |
| 2022 | 3 | 86 | 158 | $113,618 | $17,010 |
| 2021 | 1 | 34 | 76 | $58,748 | $9,836 |
| 2020 | 1 | 35 | 82 | $63,386 | $7,659 |
Total Patients
279
Total Services
593
Medicare Billing
$59,189
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 59 | 166 | $128,318 | $19,730 | 15.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $16,005 | $2,335 | 14.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2023 | 36 | 67 | $10,720 | $1,822 | 17.0% |
| G0316 | Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 2023 | 14 | 29 | $4,884 | $796.92 | 16.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 57 | 126 | $97,398 | $14,524 | 14.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 12 | 12 | $13,020 | $1,950 | 15.0% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2022 | 17 | 20 | $3,200 | $536.58 | 16.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 34 | 76 | $58,748 | $9,836 | 16.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 35 | 82 | $63,386 | $7,659 | 12.1% |
About Dr. Nicholas Butowski, MD
Dr. Nicholas Butowski, MD is a Neurological Surgery healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184681009.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicholas Butowski, MD has received a total of $70,911 in payments from pharmaceutical and medical device companies, with $2,655 received in 2024. These payments were reported across 49 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($35,791).
As a Medicare-enrolled provider, Butowski has provided services to 279 Medicare beneficiaries, totaling 593 services with total Medicare billing of $59,189. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurological Surgery
- Location San Francisco, CA
- Active Since 04/26/2006
- Last Updated 07/23/2008
- Taxonomy Code 207T00000X
- Entity Type Individual
- NPI Number 1184681009
Products in Payments
- Gliadel (Drug) $28,021
- Avastin (Biological) $5,872
- Stivarga (Drug) $2,510
- Vitrakvi (Drug) $1,199
- OPDIVO (Biological) $957.16
- TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) $44.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurological Surgery Doctors in San Francisco
Dr. Christopher Ames, Md, MD
Neurological Surgery — Payments: $7.4M
Neurological Surgery $7.4M
Dr. Praveen Mummaneni, M.d, M.D
Neurological Surgery — Payments: $1.8M
Neurological Surgery $1.8M
Dr. Lee Tan, M.d, M.D
Neurological Surgery — Payments: $536,791
Neurological Surgery $536,791
Jang Yoon, Md, MD
Neurological Surgery — Payments: $203,201
Neurological Surgery $203,201
Dr. Aaron Clark, Md, Phd, MD, PHD
Neurological Surgery — Payments: $197,841
Neurological Surgery $197,841
Dr. Isaac Yang, M.d, M.D
Neurological Surgery — Payments: $114,135
Neurological Surgery $114,135